RxDoctor Payments Data

Sandra Durrett

Family · New Albany, MSNPI 1033195953

Payments from drug & device makers

$891in general payments, 2019–2025

Across 52 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$143
  • GSK$131
  • Bausch Health US, LLC$114
  • Boehringer Ingelheim$88
  • Novo Nordisk$71
  • Lilly USA, LLC$48
  • plus $295 from 10 others

What the payments were for

  • Food & beverage$891100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$891 in reported general payments places this provider in the 65th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$41,441
Medicare patients
172
Services billed
1,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$12,642
XareltoRivaroxaban17$12,356
EliquisApixaban11$8,484
Escitalopram Oxalate59$1,037
Levothyroxine Sodium98$993
Valsartan22$820
Memantine Hcl19$747
Donepezil Hcl46$662
Atorvastatin Calcium50$653
SynthroidLevothyroxine Sodium15$629
Gabapentin33$597
Quetiapine Fumarate23$528
Omeprazole55$527
CefuroximeCefuroxime Axetil27$500
Sucralfate13$468

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$71$12,64213 claims
AbbVieSynthroid$47$62915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,007 family providers in Mississippi.

Other family in New Albany

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →